What is Cardiac Output Monitoring Devices Market Scope?
Cardiac output monitoring device is a tool to ensure tissue oxygenation which accomplished using the pulmonary artery catheter. The cardiac output monitor device allows to flow of blood to the tissue and provide information for failing circulation. The cardiac output monitoring device is used for high risk and critically ill surgical patient with whom large fluid shifts are expected along with bleeding and hemodynamic instability. The device used in conjunction with administration of fluid and vasopressors to achieve set therapeutic endpoints thereby improving patient care and outcome. The cardiac output monitor helps in cardiac function monitoring, providing an estimate of whole body perfusion oxygen delivery and allowing to understand the cause of high blood pressure.
Cardiac Output Monitoring Devices Market Dynamics:
- Increasing Instances of Cardiac Failures and Related Diseases
- Growing Demand for Non Invasive Cardiac Treatments
- Introduction to Pulmonary Artery Catheter
- Growing Availability of Healthcare Equipment across the Globe
- Invasive Cardiac Surgeries are Risky and Comparatively Expensive
- Lack of Oxygen Cylinder Availability in the Underdeveloped Regions
|Road Blocks / Challenges
- Skilled Workforce is Required to Operate the Same Machines
- Comparatively Expensive and Risky Treatments
- Growing Demand for Refurbished Healthcare Equipment
|Gaps & Opportunities
- Robust R&D Expenses in Product Development in case of Cardiac Output Monitoring Devices
- Upsurging Healthcare Infrastructure across the Emerging Economies
The Cardiac Output Monitoring Devices market study is being classified by Type (Invasive, Minimally-Invasive, Pulse Contour and Esophgeal Doppler), by Application and major geographies with country level break-up. According to AMA, the Global Cardiac Output Monitoring Devices market is expected to see growth rate of 3.64% and may see market size of USD24.97 Billion by 2027.
The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Analysts at AMA predicts that Players from United States will contribute to the maximum growth of Global Cardiac Output Monitoring Devices market throughout the predicted period.
Edwards Lifesciences (United States), Medtronic Inc. (Ireland), GE Healthcare (United States), Abbott (United States), Biotronik (Germany), ICU Medical (United States), Vytech (India), LiDCO Group (United Kingdom), PULSION Medical Systems SE (Germany) and Deltex Medical (England) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Cheetah Medical (Israel) and Tensys Medical (United States).
Analyst at AMA have segmented the market study of Global Cardiac Output Monitoring Devices market by Type, Application and Region. On the basis of Type, Non-Invasive are dominating the market in the year 2021 where as Minimally Invasive stood as second largest market share.
On the basis of application, Hospital segment is dominating the market in the year 2021 where as Clinic segment stood as second largest market.
On the basis of geography, the market of Cardiac Output Monitoring Devices has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). North America region hold largest market share in the year 2021. Europe on the other hand stood as second largest market due to the presence of key companies into the region and high technological advancement.
Market Influencers and their Development Strategies
In November 2021, Philips announced the acquisition of a France-based medical technology company Cardiologs. The acquisition will further strengthen Philips existing cardiac diagnostics and monitoring portfolio with Cardiologs' innovative software technology, electrocardiogram (ECG) analysis, and reporting services.
In November 2021 GE Healthcare announced the launch of a Modular, Scalable CT Platform. The Revolution Apex platform is the first computed tomography (CT) platform with built-in scalability for onsite CT detector upgrades from 40 mm to 80 mm or 160 mm detector coverage without having to replace the gantry. The new Revolution Apex platform has the quickest gantry speed in the world, with 0.23 seconds per rotation and 19.5-millisecond effective temporal resolution to freeze cardiac action.
Key Target AudienceCardiac Output Monitoring Device Manufacturers, Distributors and Traders, Hospitals and Clinics, Government Agencies, Healthcare Industry Associations, Research and Development Institutes and Others
Cardiac Output Monitoring Devices Market Study: Important Years
|Value (USD Billion)
|Avail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility
Customization available in this Study:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
To compete effectively, companies also require quantitative estimates of the future growth and qualitative nature of the market. AMA Research features not just specific market sizing estimates, but also include significant value-added commentary on Technological Trends and Innovations, Regulatory Policies, Market Maturity Indicators, Market Share Movements, New Entrants into the Market & Entry/Exit Barriers, Consumer Demographics, Supporting Company Financial and Cash Flow Planning, Open Up New Markets , To Seize Powerful Market Opportunities, Key Decision in Planning and to Further Expand Market Share, Identify Key Business Segments, Market Proposition & Gap Analysis.